| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |